DrugInfoSys

Human Insulin

Also known as:

Drug #360

Insulin is a small protein. It contains 51 amino acid arranged in two chains (A and B) joined together by disulfide linkage. Human Insulin is produced by semisynthetic and recombinant DNA techniques. In 1921, Banting and Best extracted insulin from the pancrease and demonstrated its therapeutic effects in diabetic dogs and human subjects. its appears to be as effective as conventional animal insulins, it appears to be considerably less immunogenic in diabetes patients than beef-pork insulins.

Primary Characteristics

Human Insulin is also known as .

It is of Natural origin and belongs to Polypeptide.

It belongs to Insulin agonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Insulin pharmacological group.

Molecular Weight: 5777.6 · Solubility in Water: slight · Solubility in Alcohol: very low · Non-proprietary name: Human Insulin.

Molecular structure of Human Insulin

Pharmacokinetics

Absorption: Human Insulin has an oral bioavailability is 1% (±1%), pre-systemic (first-pass) metabolism accounts for 100%.

Distribution: Human Insulin has a volume of distribution is 5 ml/kg. plasma protein binding is 5%.

Elimination: it is metabolised via Hepatic and Renal, plasma half-life is 3-5 min, renal excretion is 20%.

Advertisement

Indications

Human Insulin is primarily indicated in conditions like Diabetes mellitus, Hyperkalaemia, Iddm.

Contraindications

None recorded.

Dosage

Human Insulin's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
6 IU6 IUEvery 24hIMhourly
20 IU20 IUEvery 24hIMInitially
0.1 – 0.4 IU/ kgEvery 24hIVDose depends upon blood sugar level
10 IU10 IUEvery 24hSCIn divided doses. Dose depends upon blood sugar level
Paediatric Dosage (20kg)
0.375 IU/kg0.375 IU/kgEvery 24hSubcutaneous -
Neonatal Dosage (3kg)
0.375 IU/kg0.375 IU/kgEvery 24hSubcutaneous

Drug Interactions

Unknown22 interactions
2 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Human Insulin produces potentially life-threatening effects which include Hypoglycemia , Hypoglycemia, Hypoglycemia. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Human Insulin are Hypokalemia .

Warnings / Precautions

its doses will vary among patients and should be determined by the healthcare provider familiar with the patient’s metabolic needs, eating habits, and other lifestyle variablesThe dose of insulin lispro protamine when available in combination with insulin lispro (75/25 or 50/50 ratio) should be given within 15 minutes before a meal.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Multi-Ingredient Combinations

Storage Conditions

Human Insulin should be stored Inj.

Drug Classification

  1. 1.18.7.1Insulins

Manufacturers

Manufacturers of Human Insulin in Pakistan: